|
4O1L
Human Adenosine Kinase in complex with inhibitor
Deposited 2013-12-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
17–362(346 aa)
Fragment:UNP residues 17-362
Chain B
17–362(346 aa)
Fragment:UNP residues 17-362
|
Not recorded
|
MG MAGNESIUM ION × 4
HO4 5-ethynyl-7-(beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine × 3
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.50 Å
R-free 0.263
|
|
4O1L
Human Adenosine Kinase in complex with inhibitor
Deposited 2013-12-16
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
17–362(346 aa)
Fragment:UNP residues 17-362
|
Not recorded
|
MG MAGNESIUM ION × 2
HO4 5-ethynyl-7-(beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.50 Å
R-free 0.263
|
|
4O1L
Human Adenosine Kinase in complex with inhibitor
Deposited 2013-12-16
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
17–362(346 aa)
Fragment:UNP residues 17-362
|
Not recorded
|
MG MAGNESIUM ION × 2
HO4 5-ethynyl-7-(beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.50 Å
R-free 0.263
|
|
9O7P
Crystal structure of human adenosine kinase (ADK) in complex with inhibitor BKI-1817
Deposited 2025-04-15
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–345(345 aa)
|
Not recorded
|
CL CHLORIDE ION × 3
SO4 SULFATE ION × 15
A1B96 (6M)-6-{4-amino-1-[(1-methylpiperidin-4-yl)methyl]-1H-pyrazolo[3,4-d]pyrimidin-3-yl}quinolin-2(1H)-one × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;291 K;2.4M ammonium sulfate, 0.1M Citrate pH 4.0. HosaA.19365.a.VZ21.PC00201 at 18 mg/mL. Cocrystallization with 2mM inhibitor. plate 14484 A12 drop 2, Puck: PSL1601, Cryo: 2.5M lithium sulfate
|
Resolution 2.51 Å
R-free 0.246
|
|
9O7Q
Crystal structure of human adenosine kinase (ADK) in complex with inhibitor BKI-1676
Deposited 2025-04-15
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–345(345 aa)
|
Not recorded
|
A1B95 1-[(3P)-3-[6-(cyclopropyloxy)naphthalen-2-yl]-4-(methylamino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropan-2-ol × 1
SO4 SULFATE ION × 13
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;291 K;2.4M ammonium sulfate, 0.1M Citrate pH 4.0. HosaA.19365.a.VZ21.PC00201 at 18 mg/mL. Cocrystallization with 2mM inhibitor. plate 14484 A12/A8 drop 2, Puck: PSL1512, Cryo: 2.5M lithium sulfate
|
Resolution 2.81 Å
R-free 0.265
|
|
9O7R
Crystal structure of human adenosine kinase (ADK) in complex with inhibitor BKI-1553
Deposited 2025-04-15
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–345(345 aa)
|
Not recorded
|
CL CHLORIDE ION × 5
UW5 1-{4-amino-3-[6-(cyclopropyloxy)naphthalen-2-yl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl}-2-methylpropan-2-ol × 1
SO4 SULFATE ION × 14
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4;291 K;2.4M ammonium sulfate, 0.1M Citrate pH 4.0. HosaA.19365.a.VZ21.PC00201 at 18 mg/mL. Cocrystallization with 2mM inhibitor. plate 14484 A12 drop 2, Puck: PSL1502, Cryo: 2.5M lithium sulfate
|
Resolution 2.41 Å
R-free 0.258
|